kabutan

DAIKEN MEDICAL CO.,LTD, First Half Ordinary Profit Unexpectedly Revised Upward by 11%

Thu Oct 31, 2024 4:00 pm JST Earnings

7775 DAIKEN MEDICAL CO.,LTD 【J-GAAP】

Earnings Report

DAIKEN MEDICAL CO.,LTD <7775> [TSE-S] announced its financial results after the market closed on October 31st (16:00). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) increased by 11.5% from the same period last year, reaching 836 million yen, resulting in an increase in profits compared to the previous forecast of a 6.7% decrease.

The progress rate against the 1.5 billion yen full-year plan was 55.7%, also surpassing the five-year average of 51.4%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to decrease by 5.1% from the same period last year to 664 million yen.

In the most recent three-month period, from July to September (2Q), the ordinary profit grew by 7.1% from the same period last year, reaching 438 million yen. The operating profit margin rose from 16.5% in the same period last year to 17.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 4,454 605 605 429 14.9 57.5 Oct 31, 2022 J-GAAP
Apr - Sep, 2023 4,824 745 750 537 18.7 51.7 Oct 31, 2023 J-GAAP
Apr - Sep, 2024 4,914 836 836 608 21.2 55.7 Oct 31, 2024 J-GAAP
YoY +1.9% +12.2% +11.5% +13.2% +13.2%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 4,950 700 700 480 16.7 9 May 15, 2024 J-GAAP
Apr - Sep, 2024 Results 4,914 836 836 608 21.2 9 Oct 31, 2024 J-GAAP
Revision Rate -0.7% +19.4% +19.4% +26.7% +26.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 4,926 697 700 451 15.7 12 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 5,186 664 664 422 14.7 13 Oct 31, 2024 J-GAAP
YoY +5.3% -4.7% -5.1% -6.4% -6.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 9,137 1,054 1,053 712 24.8 20 May 15, 2023 J-GAAP
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 Guidance 10,100 1,500 1,500 1,030 35.9 22 May 15, 2024 J-GAAP
YoY +3.6% +4.0% +3.4% +4.3% +4.2%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 2,463 406 409 293 10.2 16.5 Oct 31, 2023 J-GAAP
Oct - Dec, 2023 2,582 492 492 351 12.2 19.1 Jan 31, 2024 J-GAAP
Jan - Mar, 2024 2,344 205 208 100 3.5 8.7 May 15, 2024 J-GAAP
Apr - Jun, 2024 2,395 397 398 289 10.1 16.6 Jul 31, 2024 J-GAAP
Jul - Sep, 2024 2,519 439 438 319 11.1 17.4 Oct 31, 2024 J-GAAP
YoY +2.3% +8.1% +7.1% +8.9% +8.9%

Related Articles